Fisons completes disposal of laboratory supplies business:
This article was originally published in Clinica
A week after surrendering to Rhone Poulenc Rorer's takeover offer, UK pharmaceutical company Fisons has completed the sale of its laboratory supplies distribution business. In August, Fisons announced that US-based Fisher Scientific would purchase the business, comprising Curtin Matheson Scientific (US) and Fisons Scientific Equipment (UK), for $310 million (see Clinica No 669, p 15), representing $301 million in cash and the assumption of $9 million of debt.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.